ID CCAH_HUMAN STANDARD; PRT; 2353 AA. AC O95180; O95802; Q8WWI6; Q96QI6; Q96RZ9; Q9NYY4; Q9NYY5; DT 15-JUL-1999 (Rel. 38, Created) DT 28-FEB-2003 (Rel. 41, Last sequence update) DT 10-OCT-2003 (Rel. 42, Last annotation update) DE Voltage-dependent T-type calcium channel alpha-1H subunit (Cav3.2) DE (Low-voltage-activated calcium channel alpha1 3.2 subunit). GN CACNA1H. OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP SEQUENCE FROM N.A. (ISOFORM 1). RC TISSUE=Heart; RX MEDLINE=98333998; PubMed=9670923; RA Cribbs L.L., Lee J.-H., Yang J., Satin J., Zhang Y., Daud A.N., RA Barclay J., Wiliamson M.P., Fox M., Rees M., Perez-Reyes E.; RT "Cloning and characterization of alpha1H from human heart, a member RT of the T-type Ca2+ channel gene family."; RL Circ. Res. 83:103-109(1998). RN [2] RP REVISIONS. RA Cribbs L.L., Lee J.-H., Yang J., Daud A.N., Perez-Reyes E.; RL Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP SEQUENCE FROM N.A. (ISOFORM 1). RC TISSUE=Thyroid carcinoma; RX MEDLINE=99127945; PubMed=9930755; RA Williams M.E., Washburn M.S., Hans M., Urrutia A., Brust P.F., RA Prodanovich P., Harpold M.M., Stauderman K.A.; RT "Structure and functional characterization of a novel human low- RT voltage activated calcium channel."; RL J. Neurochem. 72:791-799(1999). RN [4] RP SEQUENCE FROM N.A. (ISOFORM 1). RX MEDLINE=21096910; PubMed=11157797; RA Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K., RA Tufarelli C., Kearney L., Buckle V.J., Doggett N.A., Flint J., RA Higgs D.R.; RT "Sequence, structure and pathology of the fully annotated terminal 2 RT Mb of the short arm of human chromosome 16."; RL Hum. Mol. Genet. 10:339-352(2001). RN [5] RP SEQUENCE FROM N.A. (ISOFORM 2). RC TISSUE=Testis; RX MEDLINE=21864207; PubMed=11751928; RA Jagannathan S., Punt E.L., Gu Y., Arnoult C., Sakkas D., Barratt C.L., RA Publicover S.J.; RT "Identification and localization of T-type voltage-operated calcium RT channel subunits in human male germ cells. Expression of multiple RT isoforms."; RL J. Biol. Chem. 277:8449-8456(2002). RN [6] RP SEQUENCE OF 86-817 FROM N.A. RA Cobley V.E.; RL Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases. RN [7] RP SEQUENCE OF 424-661 AND 838-2373 FROM N.A. (ISOFORM 1). RA Mittman S., Agnew W.S.; RT "Organization and alternative splicing of CACNA1H."; RL Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the CC entry of calcium ions into excitable cells and are also involved CC in a variety of calcium-dependent processes, including muscle CC contraction, hormone or neurotransmitter release, gene expression, CC cell motility, cell division and cell death. The isoform alpha-1H CC gives rise to T-type calcium currents. T-type calcium channels CC belong to the "low-voltage activated (LVA)" group and are strongly CC blocked by nickel and mibefradil. A particularity of this type of CC channels is an opening at quite negative potentials, and a CC voltage-dependent inactivation. T-type channels serve pacemaking CC functions in both central neurons and cardiac nodal cells and CC support calcium signaling in secretory cells and vascular smooth CC muscle. They may also be involved in the modulation of firing CC patterns of neurons which is important for information processing CC as well as in cell growth processes. CC -!- SUBCELLULAR LOCATION: Integral membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; Synonyms=A1H-a; CC IsoId=O95180-1; Sequence=Displayed; CC Name=2; Synonyms=A1H-b; CC IsoId=O95180-2; Sequence=VSP_000949; CC -!- TISSUE SPECIFICITY: Expressed in kidney, liver, heart, brain. CC Isoform 2 seems to be testis-specific. CC -!- DOMAIN: Each of the four internal repeats contains five CC hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one CC positively charged transmembrane segment (S4). S4 segments CC probably represent the voltage-sensor and are characterized by a CC series of positively charged amino acids at every third position. CC -!- PTM: In response to raising of intracellular calcium, the T-type CC channels are activated by CaM-kinase II. CC -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunits CC family. CC -!- CAUTION: AT-AC pre mRNA splicing gives rise to the isoform 1 shown CC in this entry. The additional 20 amino acids found in the Ref.4 CC and Ref.6 sequences are due to a misunderstanding of the real type CC of splicing mechanism involved. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF051946; AAC67239.3; -. DR EMBL; AF073931; AAD17668.1; -. DR EMBL; AE006466; AAK61268.1; ALT_SEQ. DR EMBL; AJ420779; CAD12646.1; -. DR EMBL; AL031703; CAC42094.1; ALT_SEQ. DR EMBL; AF223562; AAF60162.1; -. DR EMBL; AF223563; AAF60163.1; -. DR Genew; HGNC:1395; CACNA1H. DR MIM; 607904; -. DR GO; GO:0005891; C:voltage-gated calcium channel complex; TAS. DR GO; GO:0008332; F:low voltage-gated calcium channel activity; TAS. DR GO; GO:0006936; P:muscle contraction; TAS. DR GO; GO:0007520; P:myoblast fusion; TAS. DR GO; GO:0008016; P:regulation of heart rate; TAS. DR GO; GO:0006810; P:transport; TAS. DR InterPro; IPR001682; Ca/Na_pore. DR InterPro; IPR002111; Cat_channel_TrpL. DR InterPro; IPR005821; Ion_trans. DR InterPro; IPR005820; M+channel_nlg. DR InterPro; IPR003915; PKD_2. DR InterPro; IPR005445; TVDCCAlpha1. DR Pfam; PF00520; Ion_trans; 4. DR PRINTS; PR01629; TVDCCALPHA1. KW Ionic channel; Transmembrane; Ion transport; Voltage-gated channel; KW Calcium channel; Glycoprotein; Repeat; Multigene family; KW Calcium-binding; Phosphorylation; Alternative splicing. FT REPEAT 87 422 I. FT REPEAT 779 1018 II. FT REPEAT 1281 1558 III. FT REPEAT 1602 1863 IV. FT DOMAIN 1 100 Cytoplasmic (Potential). FT TRANSMEM 101 119 S1 of repeat I (Potential). FT DOMAIN 120 139 Extracellular (Potential). FT TRANSMEM 140 160 S2 of repeat I (Potential). FT DOMAIN 161 169 Cytoplasmic (Potential). FT TRANSMEM 170 184 S3 of repeat I (Potential). FT DOMAIN 185 193 Extracellular (Potential). FT TRANSMEM 194 212 S4 of repeat I (Potential). FT DOMAIN 213 232 Cytoplasmic (Potential). FT TRANSMEM 233 253 S5 of repeat I (Potential). FT DOMAIN 254 394 Extracellular (Potential). FT TRANSMEM 395 419 S6 of repeat I (Potential). FT DOMAIN 420 793 Cytoplasmic (Potential). FT TRANSMEM 794 814 S1 of repeat II (Potential). FT DOMAIN 815 827 Extracellular (Potential). FT TRANSMEM 828 849 S2 of repeat II (Potential). FT DOMAIN 850 855 Cytoplasmic (Potential). FT TRANSMEM 856 874 S3 of repeat II (Potential). FT DOMAIN 875 882 Extracellular (Potential). FT TRANSMEM 883 906 S4 of repeat II (Potential). FT DOMAIN 907 917 Cytoplasmic (Potential). FT TRANSMEM 918 938 S5 of repeat II (Potential). FT DOMAIN 939 990 Extracellular (Potential). FT TRANSMEM 991 1015 S6 of repeat II (Potential). FT DOMAIN 1016 1290 Cytoplasmic (Potential). FT TRANSMEM 1291 1313 S1 of repeat III (Potential). FT DOMAIN 1314 1331 Extracellular (Potential). FT TRANSMEM 1332 1352 S2 of repeat III (Potential). FT DOMAIN 1353 1362 Cytoplasmic (Potential). FT TRANSMEM 1363 1382 S3 of repeat III (Potential). FT DOMAIN 1383 1396 Extracellular (Potential). FT TRANSMEM 1397 1418 S4 of repeat III (Potential). FT DOMAIN 1419 1428 Cytoplasmic (Potential). FT TRANSMEM 1429 1452 S5 of repeat III (Potential). FT DOMAIN 1453 1529 Extracellular (Potential). FT TRANSMEM 1530 1555 S6 of repeat III (Potential). FT DOMAIN 1556 1616 Cytoplasmic (Potential). FT TRANSMEM 1617 1637 S1 of repeat IV (Potential). FT DOMAIN 1638 1651 Extracellular (Potential). FT TRANSMEM 1652 1673 S2 of repeat IV (Potential). FT DOMAIN 1674 1680 Cytoplasmic (Potential). FT TRANSMEM 1681 1699 S3 of repeat IV (Potential). FT DOMAIN 1700 1713 Extracellular (Potential). FT TRANSMEM 1714 1737 S4 of repeat IV (Potential). FT DOMAIN 1738 1751 Cytoplasmic (Potential). FT TRANSMEM 1752 1772 S5 of repeat IV (Potential). FT DOMAIN 1773 1835 Extracellular (Potential). FT TRANSMEM 1836 1863 S6 of repeat IV (Potential). FT DOMAIN 1864 2353 Cytoplasmic (Potential). FT DOMAIN 520 530 Poly-His. FT DOMAIN 1107 1110 Poly-Ser. FT DOMAIN 1583 1586 Poly-Arg. FT SITE 378 378 Calcium ion selectivity and permeability FT (By similarity). FT SITE 974 974 Calcium ion selectivity and permeability FT (By similarity). FT SITE 1504 1504 Calcium ion selectivity and permeability FT (By similarity). FT SITE 1808 1808 Calcium ion selectivity and permeability FT (By similarity). FT CARBOHYD 192 192 N-linked (GlcNAc...) (Potential). FT CARBOHYD 271 271 N-linked (GlcNAc...) (Potential). FT CARBOHYD 1466 1466 N-linked (GlcNAc...) (Potential). FT VARSPLIC 1587 1592 Missing (in isoform 2). FT /FTId=VSP_000949. FT CONFLICT 7 7 A -> S (in Ref. 4). FT CONFLICT 31 31 E -> K (in Ref. 4). FT CONFLICT 55 55 A -> S (in Ref. 4). FT CONFLICT 94 94 L -> V (in Ref. 4). FT CONFLICT 215 215 S -> T (in Ref. 6). FT CONFLICT 313 313 M -> V (in Ref. 4 and 6). FT CONFLICT 640 640 P -> L (in Ref. 7; AAF60162). FT CONFLICT 664 664 V -> A (in Ref. 1 and 5). FT CONFLICT 2060 2060 R -> H (in Ref. 4). FT CONFLICT 2077 2077 R -> H (in Ref. 3 and 7; AAF60163). SQ SEQUENCE 2353 AA; 259160 MW; E13E270635173D98 CRC64; MTEGARAADE VRVPLGAPPP GPAALVGASP ESPGAPGREA ERGSELGVSP SESPAAERGA ELGADEEQRV PYPALAATVF FCLGQTTRPR SWCLRLVCNP WFEHVSMLVI MLNCVTLGMF RPCEDVECGS ERCNILEAFD AFIFAFFAVE MVIKMVALGL FGQKCYLGDT WNRLDFFIVV AGMMEYSLDG HNVSLSAIRT VRVLRPLRAI NRVPSMRILV TLLLDTLPML GNVLLLCFFV FFIFGIVGVQ LWAGLLRNRC FLDSAFVRNN NLTFLRPYYQ TEEGEENPFI CSSRRDNGMQ KCSHIPGRRE LRMPCTLGWE AYTQPQAEGV GAARNACINW NQYYNVCRSG DSNPHNGAIN FDNIGYAWIA IFQVITLEGW VDIMYYVMDA HSFYNFIYFI LLIIVGSFFM INLCLVVIAT QFSETKQRES QLMREQRARH LSNDSTLASF SEPGSCYEEL LKYVGHIFRK VKRRSLRLYA RWQSRWRKKV DPSAVQGQGP GHRQRRAGRH TASVHHLVYH HHHHHHHHYH FSHGSPRRPG PEPGACDTRL VRAGAPPSPP SPGRGPPDAE SVHSIYHADC HIEGPQERAR VAHAAATAAA SLRLATGLGT MNYPTILPSG VGSGKGSTSP GPKGKWAGGP PGTGGHGPLS LNSPDPYEKI PHVVGEHGLG QAPGHLSGLS VPCPLPSPPA GTLTCELKSC PYCTRALEDP EGELSGSESG DSDGRGVYEF TQDVRHGDRW DPTRPPRATD TPGPGPGSPQ RRAQQRAAPG EPGWMGRLWV TFSGKLRRIV DSKYFSRGIM MAILVNTLSM GVEYHEQPEE LTNALEISNI VFTSMFALEM LLKLLACGPL GYIRNPYNIF DGIIVVISVW EIVGQADGGL SVLRTFRLLR VLKLVRFLPA LRRQLVVLVK TMDNVATFCT LLMLFIFIFS ILGMHLFGCK FSLKTDTGDT VPDRKNFDSL LWAIVTVFQI LTQEDWNVVL YNGMASTSSW AALYFVALMT FGNYVLFNLL VAILVEGFQA EGDANRSDTD EDKTSVHFEE DFHKLRELQT TELKMCSLAV TPNGHLEGRG SLSPPLIMCT AATPMPTPKS SPFLDAAPSL PDSRRGSSSS GDPPLGDQKP PASLRSSPCA PWGPSGAWSS RRSSWSSLGR APSLKRRGQC GERESLLSGE GKGSTDDEAE DGRAAPGPRA TPLRRAESLD PRPLRPAALP PTKCRDRDGQ VVALPSDFFL RIDSHREDAA ELDDDSEDSC CLRLHKVLEP YKPQWCRSRE AWALYLFSPQ NRFRVSCQKV ITHKMFDHVV LVFIFLNCVT IALERPDIDP GSTERVFLSV SNYIFTAIFV AEMMVKVVAL GLLSGEHAYL QSSWNLLDGL LVLVSLVDIV VAMASAGGAK ILGVLRVLRL LRTLRPLRVI SRAPGLKLVV ETLISSLRPI GNIVLICCAF FIIFGILGVQ LFKGKFYYCE GPDTRNISTK AQCRAAHYRW VRRKYNFDNL GQALMSLFVL SSKDGWVNIM YDGLDAVGVD QQPVQNHNPW MLLYFISFLL IVSFFVLNMF VGVVVENFHK CRQHQEAEEA RRREEKRLRR LERRRRSTFP SPEAQRRPYY ADYSPTRRSI HSLCTSHYLD LFITFIICVN VITMSMEHYN QPKSLDEALK YCNYVFTIVF VFEAALKLVA FGFRRFFKDR WNQLDLAIVL LSLMGITLEE IEMSAALPIN PTIIRIMRVL RIARVLKLLK MATGMRALLD TVVQALPQVG NLGLLFMLLF FIYAALGVEL FGRLECSEDN PCEGLSRHAT FSNFGMAFLT LFRVSTGDNW NGIMKDTLRE CSREDKHCLS YLPALSPVYF VTFVLVAQFV LVNVVVAVLM KHLEESNKEA REDAELDAEI ELEMAQGPGS ARRVDADRPP LPQESPGARD APNLVARKVS VSRMLSLPND SYMFRPVVPA SAPHPRPLQE VEMETYGAGT PLGSVASVHS PPAESCASLQ IPLAVSSPAR SGEPLHALSP RGTARSPSLS RLLCRQEAVH TDSLEGKIDS PRDTLDPAEP GEKTPVRPVT QGGSLQSPPR SPRPASVRTR KHTFGQRCVS SRPAAPGGEE AEASDPADEE VSHITSSACP WQPTAEPHGP EASPVAGGER DLRRLYSVDA QGFLDKPGRA DEQWRPSAEL GSGEPGEAKA WGPEAEPALG ARRKKKMSPP CISVEPPAED EGSARPSAAE GGSTTLRRRT PSCEATPHRD SLEPTEGSGA GGDPAAKGER WGQASCRAEH LTVPSFAFEP LDLGVPSGDP FLDGSHSVTP ESRASSSGAI VPLEPPESEP PMPVGDPPEK RRGLYLTVPQ CPLEKPGSPS ATPAPGGGAD DPV //